Screening of adolescents for testicular cancer-a nationwide retrospective cohort study - Summary - MDSpire

Screening of adolescents for testicular cancer-a nationwide retrospective cohort study

  • By

  • Yair Zloof

  • Tomer Erlich

  • Maya Braun

  • Ruth Lev Bar-Or

  • Dotan Yaari

  • Emmanuel S Sirat

  • Lidor Peretz

  • Arik Eisenkraft

  • Limor Friedensohn

  • Gilad Twig

  • Amir Shlaifer

  • November 3, 2025

  • 0 min

Share

Objective:

To evaluate the effectiveness and cost-effectiveness of screening for testicular cancer in asymptomatic adolescents, amidst ongoing debate about its value.

Key Findings:
  • 43 cases of testicular cancer were identified, with an incidence rate of 3.67 per 100,000 person-years based on the total cohort.
  • Screening sensitivity was 66.7% at 6 months and 40% at 12 months.
  • Each cancer detected required screening of 75,198 adolescents, including 176 ultrasound tests and 112 specialist consultations.
  • Most cancers were diagnosed at stage I, regardless of screening.
Interpretation:

The low sensitivity and high number needed to screen, along with frequent unnecessary evaluations, indicate that routine screening of asymptomatic adolescents is ineffective and may not be a prudent use of resources.

Limitations:
  • Study population may not fully represent all demographics due to exemptions from military service and potential biases in screening practices.
  • Findings may not be generalizable to populations outside Israel.
Conclusion:

The findings do not support routine testicular cancer screening in asymptomatic adolescents due to low effectiveness and high resource utilization, suggesting a need for reevaluation of current screening guidelines.

Original Source(s)

Related Content